| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹0.65 -13.33% | 34,8757.14% |
| - | - | 820 | ₹0.8 -50% | 3,1000% |
| - | - | 840 | ₹0.75 -11.76% | 64,3251.21% |
| 00% | ₹130 0% | 850 | ₹1.4 -49.09% | 11,6250% |
| - | - | 870 | ₹5.95 0% | 7750% |
| - | - | 880 | ₹2.45 0% | 20,925-3.57% |
| 7750% | ₹78.75 0% | 890 | ₹3 -3.22% | 17,8250% |
| 3,1000% | ₹86.45 30.68% | 900 | ₹4.2 1.2% | 76,725-13.91% |
| - | - | 910 | ₹5.45 2.83% | 25,57526.92% |
| 1,5500% | ₹51.15 0% | 920 | ₹6.95 -0.71% | 54,250-9.09% |
| 56,5751.38% | ₹61.15 3.64% | 930 | ₹8.95 0.56% | 53,47527.77% |
| 24,0256.89% | ₹50.35 -2.89% | 940 | ₹11.15 -0.88% | 1,69,72513.47% |
| 1,17,8005.55% | ₹43.5 -3.01% | 950 | ₹14.05 -0.7% | 78,275-9.82% |
| 97,6509.56% | ₹37.45 -2.6% | 960 | ₹17.45 -1.69% | 2,03,05020.73% |
| 72,850-3.09% | ₹31.4 -3.82% | 970 | ₹21.45 -1.83% | 59,67542.59% |
| 1,64,30010.41% | ₹25.9 -5.12% | 980 | ₹26.5 -0.37% | 1,06,95030.18% |
| 47,27574.28% | ₹21.2 -5.98% | 990 | ₹31.45 -34.47% | 13,950200% |
| 5,91,32518.84% | ₹17.4 -6.7% | 1,000 | ₹37.7 -0.39% | 1,25,55013.28% |
| 1,24,0000% | ₹13.85 -8.88% | 1,010 | - | - |
| 1,18,575163.79% | ₹11.1 -9.75% | 1,020 | - | - |
| 40,30010.63% | ₹8.4 -14.28% | 1,030 | - | - |
| 57,35023.33% | ₹6.85 -11.61% | 1,040 | ₹67 0% | 1,5500% |
| 58,90046.15% | ₹5.15 -16.26% | 1,050 | - | - |
| 1,29,425142.02% | ₹3.75 -21.87% | 1,060 | - | - |
| 36,42538.23% | ₹2.4 -18.64% | 1,080 | ₹95 0% | 5,4250% |
| 1,58,10052.23% | ₹1.5 -14.28% | 1,100 | ₹135.85 0% | 1,5500% |
| 14,72518.75% | ₹1 -80% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
